Directors
Mitchel Sayare, Ph.D.
Chairman, President, and Chief Executive Officer, ImmunoGen, Inc.
Walter A. Blättler, Ph.D.
Executive Vice President, Science and Technology, ImmunoGen, Inc.
David W. Carter
Former Chairman and Chief Executive Officer, Xenogen Corporation
Stuart F. Feiner
Former Executive Vice President, General Counsel, and Secretary,
Inco Limited
Nicole Onetto, M.D.
Senior Vice President, Product Development and Chief Medical Officer, ZymoGenetics,
Inc.
Mark Skaletsky
Chairman and Chief Executive Officer,
Trine Pharmaceuticals, Inc.
Joseph J. Villafranca, Ph.D.
Principal and Practice Director, Pharmaceuticals/Life Sciences, Tunnell Consulting
Executive Officers
Mitchel Sayare, Ph.D.
President and Chief Executive Officer
Walter A. Blättler, Ph.D.
Executive Vice President, Science and Technology
Daniel M. Junius
Executive Vice President, Finance and Chief Financial Officer
John M. Lambert, Ph.D.
Senior Vice President, Pharmaceutical Development
Pauline Jen Ryan
Senior Vice President, Corporate Development and Operations
|
|
Corporate Headquarters
ImmunoGen, Inc.
128 Sidney Street
Cambridge, Massachusetts 02139
617 995 2500
www.ImmunoGen.com
Annual Meeting
11:00 AM on November 14, 2006
At the Offices of the Company
128 Sidney Street
Cambridge, Massachusetts 02139
Transfer Agent and Registrar
Mellon Investor Services LLC
Overpeck Center
85 Challenger Road
Ridgefield Park, New Jersey 07660-2108
800 288 9541
www.MellonInvestor.com/isd
Legal Counsel
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Boston, Massachusetts
Auditors
Ernst & Young LLP
Boston, Massachusetts
Shareholder Inquiries
Information about ImmunoGen can be
found at www.ImmunoGen.com. Inquiries
related to the Company may be directed
to the Investor Relations department at
our headquarters. Communications
related to stock and transfer requirements,
including lost stock certificates and change
of name or address, should be directed
to the Transfer Agent.
|